Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.Plos One|May 16, 2012
Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell linesAshley A Powell, Amirali H Talasaz, Haiyu Zhang, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell spatial mapping reveals alteration of cell type composition and tissue microenvironment during early colorectal cancer formationTuhin K Guha, Edward D Esplin, Aaron M Horning, et al.Journal of the National Cancer Institute|September 2, 2022
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaCristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, et al.Cancer|December 15, 2020
Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patientsJulie O Culver, Charité N Ricker, Joseph Bonner, et al.Translational Behavioral Medicine|February 1, 2018
Patient communication of cancer genetic test results in a diverse populationCharité N Ricker, Rachel B Koff, Chenxu Qu, et al.Nature Cancer|October 31, 2024
Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesisYizhou Zhu, Hayan Lee, Shannon White, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.Pageof 19